动态Holter监测中室性早搏负荷与致心律失常性右室心肌病心律失常风险的相关性
该队列研究纳入169例确诊ARVC患者,随访中位54个月,共进行723次Holter检查。每次随访Holter的24小时PVC负荷、PVC尖峰和非持续性室速均与随后12个月内持续性室性心律失常发生相关。
要点
- ARVC患者随访中PVC负荷可显著下降,均值降幅2906个/24小时。
- 每次Holter的PVC负荷、PVC尖峰和NSVT与随后12个月持续性室性心律失常风险相关。
- PVC尖峰的OR为6.20(95%CI 2.74-13.99),关联强度最高。
核心结论
- ARVC患者随访中每次Holter监测衍生的参数变化与疾病诊断后12个月内持续性室性心律失常风险相关。
研究设计与样本
- 多中心队列研究,纳入北美和欧洲6个ARVC注册中心的确诊ARVC患者,要求诊断时及随访中至少2次额外Holter监测结果。
- 共纳入169例患者(平均年龄36.3岁,SD 15.0;男性95例,56.2%),随访中位54个月(IQR 42-63),共723次Holter检查(中位每人4次,IQR 4-5)。
主要发现
- 随访期间共检测到75次PVC尖峰和67次持续性室性心律失常。
关键数值与推荐
- PVC尖峰定义为24小时内PVC负荷绝对增加≥5000个或相对增加≥75%且绝对增加≥1000个PVC。
- 采用混合逻辑回归模型评估各Holter随访变量与随后12个月内持续性室性心律失常的关联。
临床怎么用
- 对ARVC患者进行系列Holter监测,动态评估PVC负荷、PVC尖峰和NSVT,有助于识别随后12个月内持续性室性心律失常高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: A high burden of premature ventricular contractions (PVCs) at disease diagnosis has been associated with an overall higher risk of ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC). Data regarding dynamic modification of PVC burden at follow-up with Holter monitoring and its impact on arrhythmic risk in ARVC are scarce. OBJECTIVE: To describe changes in the PVC burden and to assess whether serial Holter monitoring is dynamically associated with sustained ventricular arrhythmias during follow-up in patients with ARVC. DESIGN, SETTINGS, AND PARTICIPANTS: In this cohort study, patients with a definite ARVC diagnosis, available Holter monitoring results at disease diagnosis, and at least 2 additional results of Holter monitoring during follow-up were enrolled from 6 ARVC registries in North America and Europe. Data were collected from June 1 to September 15, 2021. MAIN OUTCOMES AND MEASURES: The association between prespecified variables retrieved at each Holter monitoring follow-up (ie, overall PVC burden; presence of sudden PVC spikes, defined as absolute increase in PVC burden ≥5000 per 24 hours or a relative ≥75% increase, with an absolute increase of ≥1000 PVCs; presence of nonsustained ventricular tachycardia [NSVT]; and use of β-blockers and class III antiarrhythmic drugs) and sustained ventricular arrhythmias occurring within 12 months after that Holter examination was assessed using a mixed logistical model. RESULTS: In 169 enrolled patients with ARVC (mean [SD] age, 36.3 [15.0] years; 95 men [56.2%]), a total of 723 Holter examinations (median, 4 [IQR, 4-5] per patient) were performed during a median follow-up of 54 (IQR, 42-63) months and detected 75 PVC spikes and 67 sustained ventricular arrhythmias. The PVC burden decreased significantly from the first to the second Holter examination (mean, 2906 [95% CI, 1581-4231] PVCs per 24 hours; P < .001). A model including 24-hour PVC burden (odds ratio [OR] 1.50 [95% CI, 1.10-2.03]; P = .01), PVC spikes (OR, 6.20 [95 CI, 2.74-13.99]; P < .001), and NSVT (OR, 2.29 [95% CI, 1.10-4.51]; P = .03) at each follow-up Holter examination was associated with sustained ventricular arrhythmia occurrence in the following 12 months. CONCLUSIONS AND RELEVANCE: These findings suggest that in patients with ARVC, changes in parameters derived from each Holter examination performed during follow-up are associated with the risk of sustained ventricular arrhythmias within 12 months of disease diagnosis.
引用
- Gasperetti A, Cappelletto C, Carrick R, et al. Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. JAMA Cardiol. 2022. PMID: 35195686. doi:10.1001/jamacardio.2021.6016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。